Search results for "Clero"

showing 10 items of 2052 documents

Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preli…

2018

Background and aims: The present study aims to assess possible qEEG differences between newly diagnosed multiple sclerosis (MS) patients with or without cognitive impairment (CI). Methods: We enrolled 22 patients (18-55-years-old) treated with first-line drugs for <6 months, and 11 healthy controls. All subjects underwent neuropsychological assessment including BICAMS and BDI. EEG recordings were performed during a cognitive task (computerised “SDMT” subtest of BICAMS) and at rest. Based on neuropsychological assessment, patients were considered as affected (MSCI group) or not (MS group) by cognitive impairment. We analysed data comparing MSCI patients matched by sex, age (±5years) and e…

qEEG MS power spectrum analysis Cognitive impairmentmultiple sclerosis quantitative EEG cognitive impairmentSettore MED/26 - NeurologiaSettore BIO/09 - Fisiologia
researchProduct

Studio della qualità della vita in soggetti affetti da sclerosi multipla

2011

qualità della vita sclerosi multiplaSettore M-PSI/08 - Psicologia Clinica
researchProduct

INFLUENCE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) ON ACTION TREMOR IN MULTIPLE SCLEROSIS PATIENTS

2014

rTMSMultiple sclerosiSettore MED/26 - Neurologiatremor
researchProduct

Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis.

2005

Objective— Sedentary lifestyle is associated with increased cardiovascular events. The underlying molecular mechanisms are incompletely understood. Reactive oxygen species (ROS) contribute to endothelial dysfunction and atherosclerosis. An important source of vascular ROS is the NADPH oxidase. Methods and Results— C57BL6 mice were subjected to regular housing (physical inactivity) or voluntary training on running wheels (6 weeks). Inactivity increased vascular lipid peroxidation to 148±9% and upregulated superoxide release to 176±17% (L-012 chemiluminescence) and 188±29% (cytochrome C reduction assay), respectively. ROS production was predominantly increased in the endothelium and the medi…

rac1 GTP-Binding Proteinmedicine.medical_specialtyEndotheliumNitric Oxide Synthase Type IIIArteriosclerosisNitric Oxide Synthase Type IIBiologymedicine.disease_causechemistry.chemical_compoundMiceApolipoproteins EInternal medicinePhysical Conditioning AnimalmedicineAnimalsNADH NADPH OxidoreductasesRNA MessengerEndothelial dysfunctionLife Stylechemistry.chemical_classificationReactive oxygen speciesNADPH oxidaseSuperoxideNeuropeptidesNADPH Oxidase 1NADPH Oxidasesmedicine.diseasePhosphoproteinsMice Mutant Strainsrac GTP-Binding ProteinsMice Inbred C57BLVasodilationOxidative Stressmedicine.anatomical_structureEndocrinologychemistryNOX1biology.proteinNADPH Oxidase 1Endothelium VascularNitric Oxide SynthaseCardiology and Cardiovascular MedicineReactive Oxygen SpeciesOxidative stressArteriosclerosis, thrombosis, and vascular biology
researchProduct

Papel de la fosforilación de p27 en la serina 10 en la función endotelial y el remodelado vascular patológico

2015

El supresor tumoral p27 ha sido ampliamente implicado en multitud de procesos patológicos donde ejerce un papel protector debido a su acción antiproliferativa. Particularmente, a nivel cardiovascular, nuestro laboratorio ha demostrado que p27 protege frente al desarrollo de aterosclerosis en modelos murinos gracias a su función anti-proliferativa (1, 2). La regulación de p27 está fuertemente mediada por sus modificaciones postraduccionales, entre las que destaca su fosforilación en la serina 10 (principal modificación que sufre la proteína). Recientemente, nuestro laboratorio ha demostrado que la fosforilación de p27 en su Ser10 protege frente al desarrollo de aterosclerosis avanzada, incre…

reactividad vascularUNESCO::CIENCIAS MÉDICASaterosclerosisUNESCO::CIENCIAS DE LA VIDAp27endoteliomodelos animales:CIENCIAS MÉDICAS [UNESCO]cki:CIENCIAS DE LA VIDA [UNESCO]aneurisma aórtico abdominal
researchProduct

Red Blood Cells Distribution Width as Biomarker of Worsening in Atherosclerosis

2018

Red blood cell Distribution Width (RDW) is a parameter of the circulating erythrocytes’ size that it has reported to be associated with Cardiovascular Diseases (CVDs) [1-7]. The related mechanism of this association is not fully understood. However, RDW is an indicator of inflammation related to early inflammatory biomarkers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) [8,9]. Accordingly, systemic chronic inflammation leads to dysfunctional bone marrow with unsuccessful production of red blood cells [10]. As a result, it determines the migration of reticulocytes into the peripheral circulation, followed by an increase in circulating levels of i…

red cell distribution width cardiovascular diseasecardiovascular diseasered cell distribution widthRDW CVD AtherosclerosisSettore MED/23 - Chirurgia Cardiaca
researchProduct

Skala Niesprawności Neurologicznej Szpitala Guy jako istotne narzędzie do oceny objawów występujących u osób z SM

2017

Skala Niesprawności Neurologicznej Szpitala Guy (GNDS, The Guy’s Neurological Disability Scale) jest istotnym narzędziem służącym do pomiaru niepełnosprawności u osób ze stwardnieniem rozsianym. Służy ona do określenia poziomu funkcjonowania w dwunastu ważnych obszarach. Celem obecnych badań było opracowanie polskiej wersji językowej skali GNDS i sprawdzenie jej trafności, rzetelności oraz przydatności do oceny niepełnosprawności występującej u osób ze stwardnieniem rozsianym. Grupę badaną stanowiło 175. pacjentów z rozpoznaniem stwardnienia rozsianego. W badaniu wykorzystano Rozszerzoną Skalę Niewydolności Ruchowej – EDSS, Skalę Niesprawności Neurologicznej Szpitala Guy – GNDS, Skalę Akcep…

rehabilitacjadiagnostic techniquesThe Guy’s Neurological Disability Scaleneurologic examinationneuropsychologiabadanie neurologiczneSkala Niesprawności Neurologicznej Szpitala Guynarzędzia diagnostycznestwardnienie rozsianesclerosis multiplexrehabilitationNiepełnosprawność - Zagadnienia, Problemy, Rozwiązania
researchProduct

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection

2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been associated with several neurological disorders including headache, facial palsy, encephalitis, stroke, demyelinating disorders. The present report will discuss cases of multiple sclerosis (MS) onset and relapse both beginning early after SARS-CoV-2 infection. In both cases, magnetic resonance imaging (MRI) showed widespread bilateral subcortical and periventricular active lesions. Serum IgG against SARS-CoV-2 Spike antigens confirmed seroconversion with titers that are considered not definitely protective against possible reinfection. We hypothesize that SARS-CoV-2 infection, as previously reported for other vir…

relapseSettore MED/07 - Microbiologia E Microbiologia ClinicaonsetvirusesfungiRCOVID-19Case ReportNeurosciences. Biological psychiatry. Neuropsychiatrymultiple sclerosisRC31-1245vaccine.multiple sclerosivaccineMedicineSettore MED/26 - NeurologiaNeurology (clinical)Internal medicineRC321-571Neurology International
researchProduct

Off-Adherence Keeping (OAK) observational study: intentional off-adherence immunomodulatory multiple sclerosis treatment

2022

Aims: To evaluate how improved treatment adherence with a lower-frequency regimen/treatment of intramuscular (IM) IFN beta-1a impacts therapeutic effectiveness in relapsing-remitting multiple sclerosis (MS) patients switching from a higher-frequency injectable regimen/treatment. Patients & methods: Italian patients with relapsing-remitting MS and prior poor adherence to high-frequency injectable treatments (n = 181) were followed for 24 months after starting IM IFN beta-1a. Results: During the study, 97.4% of patients were treatment adherent; 22.1% of patients reported a relapse. The estimated probability of remaining relapse-free after 2 years was 78%. A high dropout rate (52.5%) led t…

relapsesMultiple Sclerosis Relapsing-RemittingTreatment Outcomequality of lifeRecurrenceHumansSettore MED/26 - NeurologiaInterferon-betaNeurology (clinical)multiple sclerosistreatment adherenceInterferon beta-1aintramuscular interferon beta-1aNeurodegenerative Disease Management
researchProduct

Estudio de la vía visual mediante tomografía de coherencia óptica y resonancia magnética cerebral y medular para la formulación y validación de model…

2020

Estudiar la correlación entre valores de tomografía de coherencia óptica (OCT, Optical Coherence Tomography) peripapilar y macular con volumetrías cerebrales y espinales determinadas a partir de imágenes de resonancia magnética (RM), teniendo en cuenta el tipo de esclerosis múltiple (EM) y el antecedente de neuritis óptica (NO). Formular y validar modelos matemáticos para la predicción de la discromatopsia y de la discapacidad a partir de marcadores clínicos y paraclínicos. MATERIAL Y MÉTODO: Estudio observacional, analítico y transversal de 92 pacientes de la Unidad Mixta de EM y Neurorregeneración del Hospital Universitario y Politécnico La Fe de Valencia. De cada paciente se recogieron l…

resonancia magnética (RM)esclerosis múltiplemédula espinaldiscromatopsia:CIENCIAS MÉDICAS ::Ciencias clínicas::Oftalmología [UNESCO]tomografía de coherencia óptica (OCT)UNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::Oftalmologíaneurodegeneración:CIENCIAS MÉDICAS ::Medicina interna::Neurología [UNESCO]escala expandida de discapacidad (EDSS)UNESCO::CIENCIAS MÉDICAS ::Medicina interna::Neurología
researchProduct